156 related articles for article (PubMed ID: 10030689)
1. Macrophages, estrogen and the microenvironment of breast cancer.
Mor G; Yue W; Santen RJ; Gutierrez L; Eliza M; Berstein LM; Harada N; Wang J; Lysiak J; Diano S; Naftolin F
J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):403-11. PubMed ID: 10030689
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line.
Rahideh ST; Keramatipour M; Nourbakhsh M; Koohdani F; Hoseini M; Talebi S; Shidfar F
Biochem Cell Biol; 2017 Aug; 95(4):468-473. PubMed ID: 28177754
[TBL] [Abstract][Full Text] [Related]
3. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
Long BJ; Tilghman SL; Yue W; Thiantanawat A; Grigoryev DN; Brodie AM
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):293-304. PubMed ID: 9883986
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts.
Santen RJ; Martel J; Hoagland M; Naftolin F; Roa L; Harada N; Hafer L; Zaino R; Pauley R; Santner S
Breast Cancer Res Treat; 1998; 49 Suppl 1():S93-9; discussion S109-19. PubMed ID: 9797023
[TBL] [Abstract][Full Text] [Related]
5. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
Mitropoulou TN; Tzanakakis GN; Kletsas D; Kalofonos HP; Karamanos NK
Int J Cancer; 2003 Mar; 104(2):155-60. PubMed ID: 12569569
[TBL] [Abstract][Full Text] [Related]
6. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
Abrhale T; Brodie A; Sabnis G; Macedo L; Tian C; Yue B; Serrero G
BMC Cancer; 2011 Jun; 11():231. PubMed ID: 21658239
[TBL] [Abstract][Full Text] [Related]
7. The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells.
Rahideh ST; Keramatipour M; Nourbakhsh M; Koohdani F; Hoseini M; Shidfar F
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):9-13. PubMed ID: 28364779
[TBL] [Abstract][Full Text] [Related]
8. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
Tekmal RR; Kirma N; Gill K; Fowler K
Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
[TBL] [Abstract][Full Text] [Related]
9. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
Wang J; Gildea JJ; Yue W
Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
[TBL] [Abstract][Full Text] [Related]
10. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of an aromatase inhibitor letrozole-resistant breast cancer cell model].
Chen HY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):423-8. PubMed ID: 24119901
[TBL] [Abstract][Full Text] [Related]
12. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.
Hole S; Pedersen AM; Hansen SK; Lundqvist J; Yde CW; Lykkesfeldt AE
Int J Oncol; 2015 Apr; 46(4):1481-90. PubMed ID: 25625755
[TBL] [Abstract][Full Text] [Related]
13. Aromatase in the normal breast and breast cancer.
Brodie A; Lu Q; Nakamura J
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):281-6. PubMed ID: 9365202
[TBL] [Abstract][Full Text] [Related]
14. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
16. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers.
Lu Q; Nakmura J; Savinov A; Yue W; Weisz J; Dabbs DJ; Wolz G; Brodie A
Endocrinology; 1996 Jul; 137(7):3061-8. PubMed ID: 8770932
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of aromatase and 17 beta-hydroxysteroid dehydrogenase type 4 in human THP 1 leukemia cells.
Jakob F; Homann D; Adamski J
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):555-63. PubMed ID: 8547182
[TBL] [Abstract][Full Text] [Related]
19. 17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.
Mor G; Eliza M; Song J; Wiita B; Chen S; Naftolin F
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):239-46. PubMed ID: 11850230
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
